** Shares of pharmaceuticals manufacturer Hutchmed (China)
jump as much as 11.8% to HK$25.2, their highest since Dec. 13
** Hutchmed (China), controlled by tycoon Li Ka-shing, is selling stakes in its health subsidiary for around $608 million as the billionaire and his flagship conglomerate look to ramp up capital and pivot towards core operations at the drugmaker
** Hutchmed anticipates to report a profit of $477 million before income tax from the transaction
** Hutchmed's largest shareholder is Hong Kong-listed conglomerate CK Hutchison in which the billionaire investor has a 28.1% stake
** Shares of CK Hutchison ease 1.6%
** Hang Seng Commerce & Industry Index slips 0.9%, healthcare index falls 1.4% and Hang Seng Index declines 1.5%
(Reporting by Donny Kwok)
((donny.kwok@thomsonreuters.com))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。